Publications by authors named "Castaneda Javier"

Claim this Profile
W
What is the impact of an advanced hybrid closed-loop system on weight control among people with type 1 diabetes?
Sarah Koning, Pim Dekker, Erwin Birnie, Tim van den Heuvel, Javier Castañeda

Diabetes Obes Metab· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of the temporary glycemic target feature in the medtronic MiniMed™ 780G advanced hybrid closed loop system: a real-world evidence study.
Jeremy Basset-Sagarminaga, Tim van den Heuvel, Javier Castañeda, Ohad Cohen

Acta Diabetol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A narrative review of meal management with the MiniMed™ 780G system: Evolution of dietary management in type 1 diabetes.
Shannon Edd, Maya Laron-Hirsch, Javier Castañeda, Tim van den Heuvel, Goran Petrovski

Diabetes Obes Metab· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiniMed 780G system performance in older users with type 1 diabetes: Real-world evidence and the case for stricter glycaemic targets.
Vittorino Smaniotto, Simon Heller, David O'Neal, Johan Jendle, Tali Cukierman-Yaffe, Javier Castañeda

Diabetes Obes Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Comments on Casteñeda et al. Time in Tight Range: Appropriate When Aiming for Normal Glycemic Levels With Advanced Closed-Loop System.
Castañeda Javier, van den Heuvel Tim, Cohen Ohad

Diabetes Care· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance of an Automated Insulin Delivery System in People Living With Type 2 Diabetes and Insulin Resistance: First Real-World Evidence in 26 427 Users.
Isabeau Thijs, Arcelia Arrieta, Javier Castañeda, Michael Joubert, Francesco Giorgino

J Diabetes Sci Technol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interdependence of targets for continuous glucose monitoring outcomes in type 1 diabetes with automated insulin delivery.
Javier Castañeda, Bastiaan E de Galan, Sander M J van Kuijk, Arcelia Arrieta, Tim van den Heuvel

Diabetes Obes Metab· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generating real-world evidence on diabetes technology using the CareLink Personal data management system.
Tim van den Heuvel, Javier Castañeda, Arcelia Arrieta, Benedikt Voelker, Ohad Cohen

Diabetes Obes Metab· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MiniMed 780G System Outperforms Other Automated Insulin Systems Due to Algorithm Design, Not Bias: Response to Inaccurate Allegations.
Tim van den Heuvel, Javier Castaneda, Isabeau Thijs, Arcelia Arrieta, Lou Lintereur

Diabetes Technol Ther· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Excellence in the management of Advanced Hybrid Closed-Loop Systems: Lessons from the Polish cohort.
Bartłomiej Matejko, Tim van den Heuvel, Javier Castaneda, Arcelia Arrieta, Katarzyna Cyranka

Diabetes Res Clin Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-Month Real-World Use of an Advanced Hybrid Closed-Loop System Versus Previous Therapy in a Dutch Center For Specialized Type 1 Diabetes Care.
Pim Dekker, Tim van den Heuvel, Arcelia Arrieta, Javier Castañeda, Dick Mul

J Diabetes Sci Technol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Hybrid Closed Loop in Adult Population With Type 1 Diabetes: A Substudy From the ADAPT Randomized Controlled Trial in Users of Real-Time Continuous Glucose Monitoring.
Tim van den Heuvel, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Roseline Ré, Javier Castañeda

J Diabetes Sci Technol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antifungal Synergy: Mechanistic Insights into the R-1-R Peptide and Extract as Potent Therapeutics against spp. through Proteomics.
Yerly Vargas-Casanova, Claudia Patricia Bravo-Chaucanés, Samuel de la Cámara Fuentes, Raquel Martinez-Lopez, Lucía Monteoliva, Javier Eduardo García Castañeda

Int J Mol Sci· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time in Tight Glucose Range in Type 1 Diabetes: Predictive Factors and Achievable Targets in Real-World Users of the MiniMed 780G System.
Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Tadej Battelino, Ohad Cohen

Diabetes Care· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MiniMed 780G automated insulin delivery system adapts to substantial changes in daily routine: Lessons from real world users during Ramadan.
Mohammed E Al-Sofiani, Goran Petrovski, Abdulrahman Al Shaikh, Abdullah Alguwaihes, Mohammad Al Harbi, Javier Castañeda

Diabetes Obes Metab· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future of Time-in-Range Goals in the Era of Advanced Hybrid Closed-Loop Automated Insulin Delivery Systems.
Halis K Akturk, Tadej Battelino, Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel

Diabetes Technol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celebrating the Data from 100,000 Real-World Users of the MiniMed™ 780G System in Europe, Middle East, and Africa Collected Over 3 Years: From Data to Clinical Evidence.
Pratik Choudhary, Arcelia Arrieta, Tim van den Heuvel, Javier Castañeda, Vittorino Smaniotto

Diabetes Technol Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
Shannon N Edd, Javier Castañeda, Pratik Choudhary, Ralf Kolassa, Winfried Keuthage

Diabetes Obes Metab· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system.
Javier Castañeda, Arcelia Arrieta, Tim van den Heuvel, Ohad Cohen

Diabetes Obes Metab· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the editor: Nuances from the manufacturer regarding the ABCD-DTN best practice guide on the use of MiniMed 780G advanced hybrid closed loop system.
Tim van den Heuvel, Javier Castaneda, Arcelia Arrieta, Ohad Cohen

Diabet Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: Substantial improvement in glycaemic control with each technology iteration of the MiniMed automated insulin delivery system.
Bruno Grassi, Ana Maria Gómez, Luis Eduardo Calliari, Denise Franco, Marcela Raggio, Javier Castañeda

Diabetes Obes Metab· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of time in target glucose range in real-world users of the MiniMed 780G system.
Javier Castañeda, Chantal Mathieu, Henk-Jan Aanstoot, Arcelia Arrieta, Julien Da Silva

Diabetes Obes Metab· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study.
Pratik Choudhary, Ralf Kolassa, Winfried Keuthage, Jens Kroeger, Charles Thivolet, Javier Castañeda

Lancet Diabetes Endocrinol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real-world users.
Arcelia Arrieta, Tadej Battelino, Andrea E Scaramuzza, Julien Da Silva, Javier Castañeda

Diabetes Obes Metab· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
Simona de Portu, Linda Vorrink, Roseline Re, John Shin, Javier Castaneda

BMJ Open· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis